Lara Mangravite, PhD, is President of Sage Bionetworks. Previously, she served as the director of the systems biology research group at Sage, where she focused on the application of collaborative approaches to advance understanding of disease biology and treatment outcomes at a systems level with the overriding goal of improving clinical care. Dr. Mangravite earned a BS in physics from the Pennsylvania State University and a PhD in pharmaceutical chemistry from the University of California, San Francisco. She completed a postdoctoral fellowship in cardiovascular pharmacogenomics at the Children’s Hospital Oakland Research Institute.
April 24, 2019